Categories: Entertainment

Flashforge’s MJP Wax 3D Printer Crowned 2024 Global Bestseller, Dominating the Jewelry Manufacturing Sector

HANGZHOU, China, July 7, 2025 /PRNewswire/ — Flashforge, a global leader in jewelry 3D printing solutions, announced today that its MultiJet Printing (MJP) wax 3D printer series has been certified as the World’s No.1 MJP Wax 3D Printer in 2024 Global Sales by SHANGPU GROUP. The recognition underscores Flashforge’s technological strength and growing dominance in precision jewelry manufacturing.

- Advertisement -

The WaxJet series has become the preferred solution for top jewelry brands and professional manufacturers worldwide. The WaxJet 510, launched in 2024, boasts an industry-leading, ultra-high resolution of 2900×2900×1700 DPI, 15μm layer thickness, and ±0.04mm/20mm dimensional accuracy—ideal for intricate applications such as micro-pavé and filigree. Its build volume of 289×208×100mm enables high-precision output at industrial scale.

- Advertisement -

In 2025, Flashforge launched the enhanced WaxJet 530 (WJ530), featuring a triple-printhead architecture that boosts print speed to 6.35mm/h—25–50% faster than mainstream alternatives. Capable of producing nearly 12 kg of wax models per month, the WJ530 empowers manufacturers to meet peak-season demand with greater efficiency and scale.

- Advertisement -

To address surging gold prices, Flashforge also introduced a smart manufacturing solution for hard gold jewelry, integrating MJP technology, high-precision wax materials, intelligent material management, and automated mass production. This enables 15μm-level detail, low gold loss, and minimal material waste—meeting the highest standards for both precision and appearance. It’s an ideal solution for high-value, customized designs.

- Advertisement -

Since its founding in 2011, Flashforge has remained committed to its mission of “making advanced technology more accessible,” delivering high-performance, user-friendly, and cost-effective 3D printing solutions worldwide. The company has built a robust ecosystem across FDM, MJP, and DLP technologies. Its desktop FDM printer, the Adventurer 5M (AD5M), leads global Amazon sales, while Flashforge products are distributed through over 70 countries, serving nearly one million users across 200+ regions.

- Advertisement -

“This honor belongs to every partner who has chosen Flashforge,” said Ms. Chen, Sales and Marketing Director at Flashforge. “Being ranked No.1 is not only a validation of our innovation—it fuels our drive to keep pushing boundaries. We’ll continue delivering cutting-edge products and help bring 3D printing from niche to mainstream, powering digital transformation across industries worldwide.”

- Advertisement -

Visit: https://enterprise.flashforge.com/pages/wj-530-3d-printer  

- Advertisement -

Photo – https://mma.prnewswire.com/media/2725470/Flashforge_s_MJP_Wax_3D_Printer_Crowned_2024_Global_Bestseller_Dominating.jpg
Photo – https://mma.prnewswire.com/media/2725471/Flashforge_a_global_leader_jewelry_3D_printing_solutions.jpg

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/flashforges-mjp-wax-3d-printer-crowned-2024-global-bestseller-dominating-the-jewelry-manufacturing-sector-302498789.html

- Advertisement -
PRNW Agency

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

7 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

7 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

7 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

7 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

7 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

7 hours ago